Becton Dickinson & Co. (NYSE:BDX) today reported its 1st quarterly results since its $12 billion acquisition of CareFusion closed in March, saying the deal pushed its top line up nearly 45% compared with the fiscal 3rd quarter last year. The bottom line didn’t fare as well. BD posted profits of $62 million, or 29¢ per share, on sales […]
CareFusion Corp.
New JenaValve CEO is Boston Scientific vet Carr-Brendel | Personnel Moves
JenaValve said this week that it tapped Victoria Carr-Brendel, former general manager of Boston Scientific‘s (NYSE:BSX) Bayer Interventional business, as its new chief executive officer. Carr-Brendel will replace Jan Keltjens, who served as interim CEO of the transcatheter aortic valve repair-focused company since January 2015. Keltjens will remain with the company as chairman of the board, JenaValve said. […]
FDA: CareFusion’s Avea ventilator recall is Class I
CareFusion said it’s recalling all of its Avea ventilators over a possible pressure transducer failure that may cause the units to stop functioning.
ConMed ripe for M&A | The week in medtech M&A
Analyst: ConMed ripe for M&A spree May 19, 2015 by Fink Densford ConMed, in the middle of an under-appreciated turnaround, could be poised to augment its growth via selective acquisitions, according to Leerink Partners analyst Richard Newitter. Newitter, who upgraded CNMD shares to “outperform” and boosted the price target to $64 from $60, wrote in […]